DALYs and mortality related to obesity are the consequence of the multiple comorbidities spanning from cardiovascular (CV) and metabolic diseases, such as heart failure (HF) and type 2 diabetes (T2D), to many cancers, infertility and respiratory (e.g., obstructive apnea syndrome), cutaneous (e.g
If someone is within a healthy BMI range , using weight loss injections without obesity may not be necessary
[4] [30] Orlistat's Mechanism of Action: Orlistat works exclusively in the gastrointestinal tract through a completely different mechanism: Inhibits pancreatic and gastric lipases , enzymes that break down dietary triglycerides Prevents approximately 25-30% of dietary fat absorption from the intestinal lumen Remains largely unabsorbed systemically (less than 1% enters circulation) [13] [9] Excreted primarily in feces , carrying unabsorbed fat with it Because orlistat acts locally in the gut rather than systemically, and tirzepatide works through hormonal pathways, there is no direct pharmacological interaction
Our injectors develop individualized strategies that prioritize balance, proportion, and natural-looking outcomes